NCT07426094 PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer Status RECRUITING Phase PHASE2/PHASE3
NCT07422597 Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prostate Cancer Status RECRUITING Phase NA
NCT07416812 Targeted Prostate Cancer Screening in Men With BRCA1/2 Mutations Status COMPLETED Phase NA
NCT07415135 Safety and Efficacy of PSMA-Targeted Fluorescent Contrast Agent DGPR1008 for Intraoperative Imaging in Robot-Assisted Radical Prostatectomy Status NOT_YET_RECRUITING Phase PHASE2
NCT07414940 ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium Status RECRUITING Phase PHASE1/PHASE2
NCT07407686 Improving Engagement From Underserved Communities With Prostate Cancer Genetics Services Status NOT_YET_RECRUITING Phase N/A
NCT07407283 A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT07398690 INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis Status RECRUITING Phase NA
NCT07393867 Androgen-responsive POSLUMA-guided Intra-prostatic Boost Status NOT_YET_RECRUITING Phase PHASE2
NCT07387263 Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing Status RECRUITING Phase NA
NCT07386496 The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI Status NOT_YET_RECRUITING Phase NA
NCT07386171 Micro-Ultrasound for Detecting Clinically Significant Prostate Cancer in Active Surveillance Status NOT_YET_RECRUITING Phase NA
NCT07381582 Safety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT07365397 Imaging Characteristics of Different ⁶⁸Ga-PSMA Probes in Prostate Cancer Status NOT_YET_RECRUITING Phase NA
NCT07363486 Sequential Study of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT07358806 Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT07355504 Prostate Cancer Early Detection Using Serial MRI Examinations Status NOT_YET_RECRUITING Phase NA
NCT07354919 Axelopran for Advanced Cancer in Patients Receiving Opioids Status RECRUITING Phase PHASE2
NCT07351461 Anxiety in Patients Under Active Surveillance for Localized Prostate Cancer and Their Partners. Status RECRUITING Phase N/A